Water → Tert-butyl 4-[6-[6-[6-(1,2-dihydroxyethyl)pyrazin-2-yl]pyrazolo[4,3-c]pyridin-1-yl]-2-pyridyl]piperazine-1-carboxylate

HRID 57997

Reaktionsgleichung

Reaktionsgleichung von HRID 57997
[CH:1]([C:3]1[N:8]=[C:7]([C:9]2[N:14]=[CH:13][C:12]3[CH:15]=[N:16][N:17]([C:18]4[N:23]=[C:22]([N:24]5[CH2:29][CH2:28][N:27]([C:30]([O:32][C:33]([CH3:36])([CH3:35])[CH3:34])=[O:31])[CH2:26][CH2:25]5)[CH:21]=[CH:20][CH:19]=4)[C:11]=3[CH:10]=2)[CH:6]=[N:5][CH:4]=1)=[CH2:2].[OH2:37].C[N+]1([O-])CCOCC1.[OH2:46]>CC(C)=O.[Os](=O)(=O)(=O)=O.C(O)(C)(C)C>[OH:37][CH:1]([C:3]1[N:8]=[C:7]([C:9]2[N:14]=[CH:13][C:12]3[CH:15]=[N:16][N:17]([C:18]4[N:23]=[C:22]([N:24]5[CH2:25][CH2:26][N:27]([C:30]([O:32][C:33]([CH3:36])([CH3:35])[CH3:34])=[O:31])[CH2:28][CH2:29]5)[CH:21]=[CH:20][CH:19]=4)[C:11]=3[CH:10]=2)[CH:6]=[N:5][CH:4]=1)[CH2:2][OH:46]

Komponenten

7

Edukt 3

HCID 962WaterHCID 2724197N-Methylmorpholine N-oxide monohydrateHCID 86707182Tert-butyl 4-[6-[6-(6-vinylpyrazin-2-yl)pyrazolo[4,3-c]pyridin-1-yl]-2-pyridyl]piperazine-1-carboxylate

Produkt 1

HCID 86707180Tert-butyl 4-[6-[6-[6-(1,2-dihydroxyethyl)pyrazin-2-yl]pyrazolo[4,3-c]pyridin-1-yl]-2-pyridyl]piperazine-1-carboxylateAusbeute 67 %

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 6386tert-ButanolKatalysatorHCID 30318Osmium TetroxideKatalysatorHCID 180AcetoneLösungsmittel

Versuchsvorschrift

A mixture of tert-butyl 4-[6-[6-(6-vinylpyrazin-2-yl)pyrazolo[4,3-c]pyridin-1-yl]-2-pyridyl]piperazine-1-carboxylate (513 mg; 1.06 mmol), N-methylmorpholine-N-oxide monohydrate (744 mg, 6.35 mmol) and 2.5% solution of osmium tetroxide in tert-butanol (0.6 ml, 0.04764 mmol) in 20 ml of acetone and 2.5 ml of water was stirred at room temperature for 24 hours. The mixture was filtered, mixed with water and extracted with EtOAc. The organic extracts were washed with water, 5% aq. citric acid, sat. aq. NaHCO3, brine, dried over Na2SO4 and concentrated. The residue was triturated with ethyl ether, the precipitate was collected by filtration and washed with ethyl ether affording tert-butyl 4-(6-(6-(6-(1,2-dihydroxyethyl)pyrazin-2-yl)-1H-pyrazolo[4,3-c]pyridin-1-yl)pyridin-2-yl)piperazine-1-carboxylate (424 mg, 67%). MS (ESI) m/z: 519.3 [M+H]+

Aufarbeitung

  1. filtrationThe mixture was filtered
  2. additionmixed with water
  3. extractionextracted with EtOAc
  4. washThe organic extracts were washed with water, 5% aq. citric acid, sat. aq. NaHCO3, brine
  5. dry with materialdried over Na2SO4
  6. concentrationconcentrated
  7. customThe residue was triturated with ethyl ether
  8. filtrationthe precipitate was collected by filtration
  9. washwashed with ethyl ether

Quellen und Nachweise

ORD-Eintrag
ord-5601ac2dc04a4c6d8d504c6258949961
Quelldatensatz
uspto-grants-2016_09
Patentnummer
US09434725B2

Verknüpfte Notizen

Wird geladen…